MedTrace Logo

The Membrane Adsorbing OXiris Filter in Septic Patients With AKI

NCT03914586 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2019-05-02

No results posted yet for this study

Summary

Patients with Sepsis / Septic Shock and AKI are submitted to Continuous Renal Replacement Therapy with the oXiris filter . The pro- inflammatory mediators , the endotoxin , interleukin 10 , the main cardiorespiratory indices and renal parameters are evaluated at the entry of the study and at the end of the treatment.

Conditions

Interventions

DEVICE

oXiris filter

Continuous Renal Replacement Therapy with oXiris filter

Sponsors & Collaborators

  • Baxter Healthcare Corporation

    collaborator INDUSTRY

  • FRANCO TURANI

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-10
Primary Completion
2019-12-30
Completion
2020-07-30
FDA Device
Yes

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03914586 on ClinicalTrials.gov